Sabin vaccine


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to Sabin vaccine: DPT vaccine, Salk vaccine

Sabin vaccine

[′sā·bən vak′sēn]
(immunology)
A live-poliovirus vaccine that is administered orally.
References in periodicals archive ?
About The Sabin Vaccine Institute and the Sabin Vaccine Institute Product Development Partnership
Two or three years back, because of lack of funds, NIDs were discontinued in most African countries that apparently had interrupted transmission," says Ciro de Quadros, director of international programs at the Sabin Vaccine Institute.
Being awarded funding demonstrates the Foundation's belief that the Sabin Vaccine Institute and Texas Children's Center for Vaccine Development will be successful in their research and development, and carry on the vision of Bob and Helen Kleberg in Texas.
The Sabin Vaccine Institute serves as the CaT Secretariat and is supported by a grant from the Bill & Melinda Gates Foundation.
The Sabin Vaccine Institute, established in 1993 in honor of the oral polio vaccine developer, Dr.
END7 is run by the Global Network for Neglected Tropical Diseases, an initiative of the Sabin Vaccine Institute.
Ltd has informed that it has inked a major partnership agreement to supply the Sabin Vaccine Institute with E6020, an adjuvant created in-house to boost the immune effects of vaccines, along with all relevant information related to the compound free of charge.
Peter Hotez, President of the Sabin Vaccine Institute and Distinguished Research Professor of The George Washington University Medical Center, Dr.
Before joining NYBA, Nathan led the Sabin Vaccine Institute's Cancer Vaccine Consortium and was a co-founder of the NanoBusiness Alliance (now the NanoBusiness Commercialization Association).
WASHINGTON, March 25, 2015 /PRNewswire-USNewswire/ -- The Sabin Vaccine Institute (Sabin) will present the Albert B.
Sabin Foundation Europe, in partnership with the Sabin Vaccine Institute based in Washington, D.
announced today that it has entered into a partnership agreement to supply the Sabin Vaccine Institute with E6020, an in-house developed adjuvant that enhances the immune effects of vaccines, as well as all relevant information pertaining to the compound free of charge, to support the development of vaccines for two neglected tropical diseases (NTDs)?